Presentation of Garcin Syndrome due to Lung Cancer

Slides:

Advertisements

Similar presentations

A Hole in the Heart Journal of Thoracic Oncology

Advertisements

Neoplastic Fever Caused by Lung Cancer

Kazuma Nagata, MD, Reiko Kaji, MD, Keisuke Tomii, MD

Phase II Trial of Gefitinib in Combination with Bevacizumab as First-Line Therapy for Advanced Non–Small Cell Lung Cancer with Activating EGFR Gene Mutations:

Inflammatory Myofibroblastic Tumor of the Left Main Stem Bronchus

Next Generation Sequencing Uncovers Potential Genetic Driver Mutations of Malignant Pulmonary Granular Cell Tumor Song Xu, Qingchun Zhao, Sen Wei, Yi.

Hironori Yoshida, MD, Young Hak Kim, MD Journal of Thoracic Oncology

Abscopal Effect of Nivolumab in a Patient with Primary Lung Cancer

Lungs on Fire Journal of Thoracic Oncology

Radiation Necrosis Mimicking Progressive Brain Metastasis in a Patient with Non-small Cell Lung Cancer Kadoaki Ohashi, MD, Kastuyuki Kiura, MD, PhD,

Leptomeningeal and Medullary Response to Second-Line Erlotinib in Lung Adenocarcinoma Mathilde Wagner, MD, Benjamin Besse, MD, Corinne Balleyguier, MD,

Severe Local Toxicity after Lung Stereotactic Body Radiation Therapy: Lesional Abscess Leading to Bronchocutaneous Fistula Requiring Surgical Marsupialization

David T. Cooke, MD, Dennis J. Zheng, Karen A. Peterson, NP, Royce F

Garcin syndrome associated with metastatic colorectal carcinoma

Electronic Updates for JTO Readers

Rapid Response of Brain Metastasis to Crizotinib in a Patient with ALK Rearrangement– Positive Non–Small-Cell Lung Cancer Hiroyasu Kaneda, MD, PhD, Isamu.

The Moth-Eaten Lung Journal of Thoracic Oncology

A Case of Large-Cell Neuroendocrine Carcinoma Harboring an EML4–ALK Rearrangement with Resistance to the ALK Inhibitor Crizotinib Naoki Omachi, MD, Shigeki.

Osimertinib Dose Escalation Induces Regression of Progressive EGFR T790M–Mutant Leptomeningeal Lung Adenocarcinoma Christine Cordova, MD, Andrew S. Chi,

Hironori Yoshida, MD, Young Hak Kim, MD Journal of Thoracic Oncology

Coexistence of the BRAF Mutation and EGFR Exon 20 Insertion in a Patient with Lung Adenocarcinoma Lih-Chyun Chang, MD, Kuan-Yu Chen, MD, PhD, Jin-Yuan.

A Long-Term Spinal Intramedullary Response to Ceritinib in ALK Rearranged Non– Small-Cell Lung Cancer Josette Biya, MD, Caroline Caramella, MD, Colin.

A Case of Squamous Cell Carcinoma Harboring an EML4-ALK Rearrangement that Was Unsuccessfully Treated with the ALK Inhibitor Alectinib Akihiro Tamiya,

Erlotinib Accumulation in Brain Metastases from Non-small Cell Lung Cancer: Visualization by Positron Emission Tomography in a Patient Harboring a Mutation.

Neoplastic Fever Caused by Lung Cancer

Multiple Pulmonary Chondromas in a Young Female Patient: A Component of Carney Triad Gui-Bin Qiao, MD, PhD, Wei-Sheng Zeng, MD, Li-Jun Peng, MD, Wen-Zhao.

A Severe Photosensitivity Dermatitis Caused by Crizotinib

The Central Nervous System as a Sanctuary Site in ALK-Positive Non–Small-Cell Lung Cancer Justin F. Gainor, MD, Sai-Hong Ignatius Ou, MD, PhD, Jennifer.

Multiple Pulmonary Chondroid Hamartoma

Triple Combination Chemotherapy with Cisplatin, Docetaxel, and Irinotecan for Advanced Non-small Cell Lung Cancer: A Phase I/II Trial Katsuyuki Kiura,

Synchronous Pulmonary MALT Lymphoma and Pulmonary Adenocarcinoma after Metachronous Gastric MALT Lymphoma and Gastric Adenocarcinoma Eiki Ichihara, MD,

Calcified amorphous tumor of left atrium

Vipul Pareek, MD, Mary Welch, MD, Elizabeth Ravera, RN, Richard L

Phase II Trial of Gefitinib in Combination with Bevacizumab as First-Line Therapy for Advanced Non–Small Cell Lung Cancer with Activating EGFR Gene Mutations:

Association between Congenital Lung Malformations and Lung Tumors in Children and Adults: A Systematic Review Arianna Casagrande, MD, Federica Pederiva,

Bilateral Subdural Hematoma Associated with Central Nervous System Metastases from Lung Cancer Akito Hata, MD, Shiro Fujita, MD, PhD, Nobuyuki Katakami,

Salvage Operation in Case of Oligometastatic Disease

Disease Flare After Treatment Discontinuation in a Patient With EML4-ALK Lung Cancer and Acquired Resistance to Crizotinib Oana Pop, MD, Augustin Pirvu,

Mecit Kantarci, MD, PhD, Fadime Fil, MD, Ummugulsum Bayraktutan, MD

Vamsidhar Velcheti, MD, Manmeet Ahluwalia, MD

Massive Bronchogenic Cyst

A Hole in the Heart Journal of Thoracic Oncology

Do Complex Mutations of the Epidermal Growth Factor Receptor Gene Reflect Intratumoral Heterogeneity? Akito Hata, MD, Shiro Fujita, MD, PhD, Reiko Kaji,

Ineffectiveness of Crizotinib on Brain Metastases in Two Cases of Lung Adenocarcinoma with EML4-ALK Rearrangement Denis Maillet, MD, Isabelle Martel-Lafay,

Nivolumab-Induced Acute Diabetes Mellitus and Hypophysitis in a Patient with Advanced Pulmonary Pleomorphic Carcinoma with a Prolonged Tumor Response

Osteoblastic Bone Lesions Developing During Treatment with Erlotinib Indicate Major Response in Patients with Non-small Cell Lung Cancer: A Brief Report

The Role of Surgery in the Management of Primary Thymic Mucosa-associated Lymphoid Tissue (MALT) Lymphoma Kimihiro Shimizu, MD, PhD, Izumi Takeyoshi,

Nasion Swelling as the Presenting Symptom of Lung Adenocarcinoma

A Case of Nontuberculous Mycobacteria Highly Suspected as Lung Cancer Invading the Aortic Arch Tadashi Umehara, MD, Masaya Aoki, MD, PhD, Aya Harada,

Matthew Reichert, MD, Eric S. Bensadoun, MD

Relationship between Response and Survival in More Than 50,000 Patients with Advanced Non-small Cell Lung Cancer Treated with Systemic Chemotherapy in.

Impact of HER2 Gene and Protein Status on the Treatment Outcome of Cisplatin-Based Chemoradiotherapy for Locally Advanced Non-small Cell Lung Cancer

Multiple Pulmonary Nodules in an Elderly Woman

A Phase II Trial of Erlotinib Monotherapy in Pretreated Patients with Advanced Non- small Cell Lung Cancer Who Do Not Possess Active EGFR Mutations: Okayama.

T4 or MI? Journal of Thoracic Oncology Volume 6, Issue 3, (March 2011)

Paraneoplastic Limbic Encephalitis Attributable to Thymoma

Giant Desmoid Tumor of the Chest Wall

Antiangiogenesis Induced Tumor Cavitation in Lung Cancer

Transvenous Metastasis to the Heart

Occlusive Endobronchial Stent Placement as a Novel Management Approach to Massive Hemoptysis from Lung Cancer Johann C. Brandes, MD, PhD, Eric Schmidt,

Recurrent Primary Synovial Sarcoma of the Chest Wall

Andreas Rimner, MD, Kenneth E. Rosenzweig, MD

Metastatic Lung Cancer to the Pancreas

Benefits and Adverse Events Among Elderly Patients Receiving Concurrent Chemoradiotherapy for Locally Advanced Non-small Cell Lung Cancer: Analysis of.

Tumor Lysis Syndrome in Limited-Stage Small-Cell Lung Cancer

Complete and Durable Response of Choroid Metastasis from Non-small Cell Lung Cancer with Systemic Bevacizumab and Chemotherapy Ben George, MD, William.

David Garfield, MD Journal of Thoracic Oncology

Paraneoplastic Limbic Encephalitis due to Thymic Carcinoid

Popcorn in the Lung Journal of Thoracic Oncology

Super Scan Using Positron Emission Tomography in Lung Cancer Patients

Presentation transcript:

Presentation of Garcin Syndrome due to Lung Cancer Masanori Fujii, MD, Katsuyuki Kiura, MD, PhD, Nagio Takigawa, MD, PhD, Tetsuya Yumoto, MD, Yoshihide Sehara, MD, Masahiro Tabata, MD, PhD, Mitsune Tanimoto, MD, PhD Journal of Thoracic Oncology Volume 2, Issue 9, Pages 877-878 (September 2007) DOI: 10.1097/JTO.0b013e31811f473d Copyright © 2007 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 1 Gadolinium-enhanced magnetic resonance imaging of the brain revealed an extra-axial enhanced lesion near the left cerebellopontine angle. The tumor extended along the left skull base on horizontal (A) and coronal (B) images. The tumor invaded from the optic canal to the hypoglossal canal. The arrows indicate the tumor around the left internal acoustic foramen. Journal of Thoracic Oncology 2007 2, 877-878DOI: (10.1097/JTO.0b013e31811f473d) Copyright © 2007 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 2 Computed tomography of the chest showed the presence of a tumor in the left lower lobe. Journal of Thoracic Oncology 2007 2, 877-878DOI: (10.1097/JTO.0b013e31811f473d) Copyright © 2007 International Association for the Study of Lung Cancer Terms and Conditions